Isodiol revenue breakdown by business segment: 100.0% from PHARMACEUTICAL DIVERSIFIED
CAD | FY, 2018 | FY, 2019 |
---|---|---|
Revenue | 19.1m | 22.2m |
Cost of goods sold | (10.3m) | (14.9m) |
Gross profit | 8.9m | 7.4m |
R&D expense | (602.0k) | (107.0k) |
Operating expense total | (42.1m) | (37.9m) |
Depreciation and amortization | (1.1m) | (2.1m) |
EBITDA | (33.3m) | (30.5m) |
EBIT | (34.8m) | (75.0m) |
Interest expense | (2.0k) | (6.0m) |
Pre tax profit | (35.7m) | (120.9m) |
Income tax expense | (293.0k) | 301.0k |
Net Income | (36.0m) | (120.6m) |
CAD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|
Revenue | 9.2m | 8.0m | 7.1m | 4.2m | 1.9m | 1.3m |
Cost of goods sold | (4.6m) | (3.7m) | (3.5m) | (3.1m) | (1.5m) | (835.0k) |
Gross profit | 4.6m | 4.3m | 3.6m | 1.1m | 403.0k | 490.0k |
R&D expense | (212.0k) | (137.0k) | 139.0k | |||
Operating expense total | (7.6m) | (11.9m) | (8.2m) | (2.8m) | (2.5m) | (1.2m) |
Depreciation and amortization | (698.0k) | (954.0k) | (1.0m) | (89.0k) | (89.0k) | (89.0k) |
EBITDA | (3.0m) | (7.6m) | (4.6m) | (1.8m) | (2.1m) | (702.0k) |
EBIT | (3.7m) | (8.5m) | (5.7m) | (2.4m) | (2.8m) | (292.0k) |
Interest expense | (10.0k) | (27.0k) | (151.0k) | (90.0k) | (90.0k) | (176.0k) |
Interest income | 87.0k | 84.0k | 84.0k | |||
Pre tax profit | (3.8m) | (8.6m) | (18.2m) | (2.8m) | (3.2m) | (787.0k) |
Net Income | (3.8m) | (8.6m) | (18.2m) | (2.8m) | (3.2m) | (787.0k) |
CAD | FY, 2018 | FY, 2019 |
---|---|---|
Cash | 15.6m | 404.0k |
Accounts Receivable | 1.0m | 2.8m |
Prepaid Expenses | 1.1m | 2.9m |
Inventories | 1.8m | 859.0k |
Current Assets | 22.8m | 16.9m |
PP&E | 1.1m | 1.6m |
Goodwill | 13.0m | |
Total Assets | 54.5m | 23.6m |
Accounts Payable | 5.4m | 5.5m |
Short-term debt | 2.9m | |
Current Liabilities | 6.7m | 11.5m |
Long-term debt | 5.2m | |
Non-Current Liabilities | 5.2m | |
Total Debt | 8.1m | |
Total Liabilities | 6.7m | 16.7m |
Common Stock | 90.1m | 177.0m |
Retained Earnings | (50.0m) | (175.3m) |
Total Equity | 47.8m | 6.9m |
CAD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|
Cash | 11.5m | 3.3m | 2.5m | 3.2m | 303.0k | 239.0k |
Accounts Receivable | 6.1m | 3.8m | 5.4m | 1.6m | 2.3m | 686.0k |
Prepaid Expenses | 4.2m | 6.4m | 5.4m | 2.9m | 2.6m | 551.0k |
Inventories | 5.8m | 6.7m | 6.8m | 1.0m | 1.0m | 2.6m |
Current Assets | 32.0m | 22.8m | 22.3m | 13.2m | 10.3m | 6.7m |
PP&E | 9.5m | 9.9m | 8.0m | 1.5m | 1.4m | 1.4m |
Goodwill | 109.4m | 109.4m | 108.8m | |||
Total Assets | 177.1m | 169.2m | 155.1m | 17.7m | 14.7m | 11.0m |
Accounts Payable | 4.3m | 3.5m | 3.0m | 5.8m | 5.9m | 3.2m |
Short-term debt | 445.0k | 2.9m | 3.0m | 170.0k | ||
Current Liabilities | 50.7m | 50.4m | 45.7m | 8.4m | 8.5m | 5.8m |
Long-term debt | 5.3m | 5.3m | 5.6m | 5.2m | ||
Non-Current Liabilities | 12.9m | 12.9m | 18.2m | 5.7m | 5.6m | 5.7m |
Total Debt | 445.0k | 2.9m | 8.3m | 5.3m | 5.8m | 5.2m |
Total Liabilities | 63.6m | 63.2m | 63.9m | 14.1m | 14.0m | 11.4m |
Common Stock | 159.7m | 162.2m | 164.4m | 178.3m | 178.3m | 178.3m |
Retained Earnings | (53.9m) | (62.2m) | (79.9m) | (178.6m) | (181.9m) | (182.7m) |
Total Equity | 113.5m | 106.0m | 91.2m | 3.6m | 626.0k | (414.0k) |
CAD | FY, 2018 | FY, 2019 |
---|---|---|
Net Income | (36.0m) | (125.9m) |
Depreciation and Amortization | 1.1m | 2.1m |
Accounts Receivable | (3.9m) | (6.5m) |
Inventories | (1.8m) | 981.0k |
Accounts Payable | (206.0k) | 5.7m |
Cash From Operating Activities | (23.5m) | (24.0m) |
Cash From Investing Activities | (16.6m) | (16.5m) |
Short-term Borrowings | 2.4m | |
Long-term Borrowings | 5.5m | |
Cash From Financing Activities | 55.1m | 24.7m |
Net Change in Cash | 14.8m | (15.1m) |
CAD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|
Net Income | (3.8m) | (12.4m) | (30.6m) | (2.8m) | (6.1m) | (6.9m) |
Depreciation and Amortization | 697.0k | 1.7m | 2.7m | 89.0k | 178.0k | 267.0k |
Accounts Receivable | (3.7m) | (2.2m) | (3.1m) | 8.2m | 7.1m | 10.6m |
Inventories | (4.0m) | (4.8m) | (5.0m) | (154.0k) | (189.0k) | (1.7m) |
Accounts Payable | (137.0k) | (564.0k) | (4.4m) | 841.0k | 1.0m | (1.7m) |
Cash From Operating Activities | (13.8m) | (21.1m) | (29.9m) | 5.5m | 2.4m | 2.6m |
Cash From Investing Activities | (6.0m) | (10.4m) | (9.3m) | 1.4m | 1.7m | 1.7m |
Short-term Borrowings | 2.4m | 2.5m | (2.9m) | (2.9m) | (2.9m) | |
Long-term Borrowings | 6.0m | (433.0k) | (249.0k) | |||
Cash From Financing Activities | 15.5m | 18.6m | 24.8m | (3.0m) | (3.3m) | (3.3m) |
Net Change in Cash | (4.0m) | (12.3m) | (13.0m) | 2.8m | (100.0k) | (165.0k) |
CAD | FY, 2018 |
---|---|
Revenue/Employee | 335.7k |